Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: the Escala study
Main Authors: | , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer Berlin Heidelberg
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608957/ |